IFN-γ contributes to the hepatic inflammation in HFD-induced nonalcoholic steatohepatitis by STAT1β/TLR2 signaling pathway

•IFN-γ and TLR2 expression upregulated significantly in E3 rats NASH animal model.•IFN-γ positively regulated TLR2, TNF-α, IL6, p-STAT1 and IRF1 in cells consistently.•IFN-γ promotes TLR2 transcription and its target genes production by STAT1β. Growing research evidence suggests that elevated TLR2 i...

Full description

Saved in:
Bibliographic Details
Published inMolecular immunology Vol. 134; pp. 118 - 128
Main Authors Li, Jing, Chen, Qian, Yi, Jing, Lan, Xi, Lu, Kaikai, Du, Xiaojuan, Guo, Zizhen, Guo, Yuanxu, Geng, Manman, Li, Dongmin, Lu, Shemin
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.06.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•IFN-γ and TLR2 expression upregulated significantly in E3 rats NASH animal model.•IFN-γ positively regulated TLR2, TNF-α, IL6, p-STAT1 and IRF1 in cells consistently.•IFN-γ promotes TLR2 transcription and its target genes production by STAT1β. Growing research evidence suggests that elevated TLR2 is closely related to the occurrence and development of nonalcoholic steatohepatitis (NASH). However, a little is known about its regulatory mechanism. Here, we found that IFN-γ and TLR2 expression is significantly upregulated in NASH associated rat liver specimens. Meanwhile, IFN-γ positively regulated the expression of TLR2 and its target genes in NR8383 rat macrophage cells in dose- & time-dependent manner. Importantly, IFN-γ also regulated the related transcriptional factors pSTAT1 and IRF1. Moreover, we identified that the DNA fragment from −1000 to −200 bp of the TLR2 promoter region is responsible for STAT1 binding, especially the STAT1-BS3 (−591∼−573 bp). Further investigation verified that STAT1β is essential in this process, rather than STAT1α. Overall, our findings suggest that IFN-γ promotes TLR2 transcription and its target genes expression by STAT1β. This leads to the hepatic inflammation vicious cycle in NASH and provides new potential targets for treating NASH.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0161-5890
1872-9142
DOI:10.1016/j.molimm.2021.03.005